Comparative immunochemical and biological analysis of African and South American yellow fever viruses
- PMID: 2437890
- DOI: 10.1007/BF01310727
Comparative immunochemical and biological analysis of African and South American yellow fever viruses
Abstract
Four geographic variants (topotypes) of yellow fever (YF) virus from Africa and South America previously determined by RNA oligonucleotide mapping were analyzed for their structural, antigenic and virulence characteristics. The electrophoretic migration mobility and carbohydrate content of the envelope protein E characterized YF virus strains of South America. The NS 1 protein of South American and Central African YF virus strains was not precipitated by anti-NS 1 monoclonal antibodies (MAB) that precipitated NS 1 of West African strains. No distinction could be made among the YF virus strains on the basis of the neutralizing capacity of available MAB. South American, but not African YF virus strains were virulent for 8-day-old mice upon intraperitoneal inoculation. The results permitted characterization of topotypes of Central Africa and South America but failed to differentiate YF strains from West Africa.
Similar articles
-
Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein.Virology. 1983 Feb;125(1):8-17. doi: 10.1016/0042-6822(83)90059-4. Virology. 1983. PMID: 6187129
-
Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.J Gen Virol. 1985 Jul;66 ( Pt 7):1369-82. doi: 10.1099/0022-1317-66-7-1369. J Gen Virol. 1985. PMID: 2410549
-
Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.Clin Vaccine Immunol. 2016 Aug 5;23(8):689-97. doi: 10.1128/CVI.00209-16. Print 2016 Aug. Clin Vaccine Immunol. 2016. PMID: 27307452 Free PMC article.
-
Yellow fever: a disease that has yet to be conquered.Annu Rev Entomol. 2007;52:209-29. doi: 10.1146/annurev.ento.52.110405.091454. Annu Rev Entomol. 2007. PMID: 16913829 Review.
-
[Molecular epidemiology of yellow fever].Med Trop (Mars). 1998;58(2 Suppl):37-41. Med Trop (Mars). 1998. PMID: 9812309 Review. French.
Cited by
-
Nucleotide sequence variation of the envelope protein gene identifies two distinct genotypes of yellow fever virus.J Virol. 1995 Sep;69(9):5773-80. doi: 10.1128/JVI.69.9.5773-5780.1995. J Virol. 1995. PMID: 7637022 Free PMC article.
-
Current Assessment of Yellow Fever and Yellow Fever Vaccine.Curr Infect Dis Rep. 2004 Apr;6(2):96-104. doi: 10.1007/s11908-996-0005-9. Curr Infect Dis Rep. 2004. PMID: 15023271
-
Processing of yellow fever virus polyprotein: role of cellular proteases in maturation of the structural proteins.J Virol. 1989 Oct;63(10):4199-209. doi: 10.1128/JVI.63.10.4199-4209.1989. J Virol. 1989. PMID: 2674479 Free PMC article.
-
A mouse model for studying viscerotropic disease caused by yellow fever virus infection.PLoS Pathog. 2009 Oct;5(10):e1000614. doi: 10.1371/journal.ppat.1000614. Epub 2009 Oct 9. PLoS Pathog. 2009. PMID: 19816561 Free PMC article.
-
Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells.Virology. 1989 Apr;169(2):354-64. doi: 10.1016/0042-6822(89)90161-x. Virology. 1989. PMID: 2523178 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous